News | October 21, 2009

First Trial Implants Made With New GORE TAG Thoracic Endoprosthesis

October 21, 2009 – W. L. Gore and Associates today announced the first human implants of the next generation Conformable GORE TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs).

The first implants were performed by Joshua Rovin, M.D. and Eugene Murphy, M.D., at Bayfront Medical Center and William McMillan, M.D. and Scott Schultz, M.D., at North Memorial Medical Center. The devices were used to treat patients with a TAA, which is an enlargement that develops in weakened areas in the thoracic aorta.

Gore received approval of an investigational device exemption (IDE) from the FDA to investigate the use of the next generation Conformable GORE TAG Thoracic Endoprosthesis in TAAs. William Jordan, MD, from the University of Alabama, Birmingham, will serve as the national principle investigator in the Conformable GORE TAG Device in Thoracic Aortic Aneurysm Trial (Gore TAG 08-03). “This study will evaluate device performance across the wide portfolio of sizes available with the next generation Conformable GORE TAG Device,” Dr. Jordan said. The next generation device portfolio includes device diameters ranging from 21–45 mm, as well as tapered devices, and the study will investigate the treatment of patients with aortic diameters of 16–42 mm.

The commercially available GORE TAG Thoracic Endoprosthesis provides a minimally invasive option for safely and effectively treating patients with aneurysms of the descending thoracic aorta (DTA). It is comprised of an ePTFE graft with an outer self-expanding nitinol support structure to combine both device flexibility and material durability. It received pre-market approval from the FDA in 2005.

In addition to TAAs, the next generation Conformable GORE TAG Device has been approved to investigate endovascular repair of other etiologies including traumatic aortic transection and aortic dissection. Design enhancements include a modified stent frame, repositioned gold bands, and optimized graft material.

For more information: www.goremedical.com

Related Content

First U.S. Patient Receives Gore Tag Conformable Thoracic Stent Graft With Active Control
News | Stent Grafts | July 10, 2019
W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable Thoracic Stent...
Gore Receives FDA Approval for Gore Tag Conformable Thoracic Stent Graft
Technology | Stent Grafts | May 15, 2019
W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted regulatory...
Aortic Stent Graft Global Market to Reach $5.4 Billion by 2028
News | Stent Grafts | February 14, 2019
Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft market at least through...
Medtronic Receives FDA Approval for Valiant Navion Thoracic Stent Graft System
Technology | Stent Grafts | February 07, 2019
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant Navion thoracic stent...
Endologix Ends Unrestricted Sales and Use of Nellix System
News | Stent Grafts | January 07, 2019
January 7, 2019 — Endologix Inc.
Endologix Reports Positive One-Year Results From the Ovation LUCY Study
News | Stent Grafts | July 16, 2018
Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for...
FDA Committee Votes in Favor of Incraft AAA Stent Graft System
News | Stent Grafts | June 13, 2018
Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has received a favorable...
First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.
FDA Concerned About Increase in stent graft Endovascular Type III Leaks
News | Stent Grafts | October 09, 2017
October 9, 2017 — The U.S.
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts | July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
Overlay Init